Interesting- I also saw this article for Bristol yesterday,"Bristol-Myers Squibb Co. shares had their second-biggest rally since March and bullish options trading surged on speculation the company is a takeover candidate. The drugmaker’s cancer and heart treatments would make it an interesting acquisition for Gilead Sciences Inc., though it could be too big to absorb without affecting the larger company’s identity, analysts at Piper Jaffray said Friday in a research note. Gilead had a market value of $159 billion as of Friday’s close, compared with Bristol-Myers’ $107 billion."